Glenmede Trust Co. NA Has $8.15 Million Stake in Humana Inc. (NYSE:HUM)

Glenmede Trust Co. NA lifted its holdings in Humana Inc. (NYSE:HUM) by 7.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 25,718 shares of the insurance provider’s stock after buying an additional 1,813 shares during the period. Glenmede Trust Co. NA’s holdings in Humana were worth $8,146,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Creative Financial Designs Inc. ADV lifted its position in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. boosted its position in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares during the last quarter. Atwood & Palmer Inc. purchased a new position in Humana in the third quarter valued at about $29,000. Ashton Thomas Securities LLC acquired a new position in Humana in the 3rd quarter worth about $31,000. Finally, Your Advocates Ltd. LLP raised its stake in shares of Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Stock Up 0.0 %

HUM stock opened at $296.78 on Friday. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $504.79. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The company has a market cap of $35.74 billion, a PE ratio of 26.29, a price-to-earnings-growth ratio of 2.34 and a beta of 0.52. The business’s 50-day simple moving average is $275.33 and its 200 day simple moving average is $329.47.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, research analysts anticipate that Humana Inc. will post 15.86 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.19%. The ex-dividend date is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

Wall Street Analyst Weigh In

HUM has been the subject of several recent research reports. TD Cowen boosted their price target on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Jefferies Financial Group cut shares of Humana from a “buy” rating to a “hold” rating and reduced their target price for the company from $519.00 to $253.00 in a research note on Monday, October 7th. Stephens restated an “equal weight” rating and set a $250.00 price target on shares of Humana in a research note on Wednesday, October 9th. KeyCorp started coverage on shares of Humana in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Finally, JPMorgan Chase & Co. upped their price objective on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st. Twenty equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, Humana presently has an average rating of “Hold” and a consensus price target of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.